Matches in Wikidata for { <http://www.wikidata.org/entity/Q58481768> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q58481768 description "article published in 2015" @default.
- Q58481768 description "im Januar 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58481768 description "wetenschappelijk artikel" @default.
- Q58481768 description "наукова стаття, опублікована в січні 2015" @default.
- Q58481768 name "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 name "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 type Item @default.
- Q58481768 label "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 label "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 prefLabel "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 prefLabel "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 P1433 Q58481768-DC811CCE-7A23-447E-AC80-87F7FAEF5FE4 @default.
- Q58481768 P1476 Q58481768-F72D4D8D-22A9-4EB0-B786-5F6F5BB597AF @default.
- Q58481768 P304 Q58481768-A6809FA1-02EE-4500-95E4-4F903630DACE @default.
- Q58481768 P31 Q58481768-15A01165-10F8-4FEC-91FF-5FA9D9E9D588 @default.
- Q58481768 P356 Q58481768-46BDD76C-6317-4951-9F59-4725BF3917D5 @default.
- Q58481768 P407 Q58481768-1F759CA6-72B7-4E1F-9B50-33CAFA4E3073 @default.
- Q58481768 P433 Q58481768-53B07CF6-24AB-4A33-BB23-F2A27057E343 @default.
- Q58481768 P478 Q58481768-6FA981CB-4D6E-4A90-9487-235698F3617C @default.
- Q58481768 P577 Q58481768-985B8291-7AED-44DD-A556-A96872FF386D @default.
- Q58481768 P921 Q58481768-E3ABC08A-1FCF-45D1-8ABB-F6FE09D26EFF @default.
- Q58481768 P356 BLOOD-2014-12-617654 @default.
- Q58481768 P1433 Q885070 @default.
- Q58481768 P1476 "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430" @default.
- Q58481768 P304 "890-890" @default.
- Q58481768 P31 Q13442814 @default.
- Q58481768 P356 "10.1182/BLOOD-2014-12-617654" @default.
- Q58481768 P407 Q1860 @default.
- Q58481768 P433 "5" @default.
- Q58481768 P478 "125" @default.
- Q58481768 P577 "2015-01-29T00:00:00Z" @default.
- Q58481768 P921 Q18553852 @default.